Maxitrol

Medicinal product

(Invented) name

Maxitrol

Active substance (s)

Deksametazonas/Neomicino sulfatas/Polimiksino B sulfatas

Strength

1 mg/3500 TV/6000 TV/ml

Pharmaceutical form

akių lašai (suspensija)

Route (s) of administration

vartoti ant akių

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01CA01, Dexamethasone and antiinfectives

Marketing authorisation holder

UAB Limedika, Lietuva

Date of authorisation

2018-06-18

Date of renewal

Documents

0672_Maxitrol lasai_PZPL_2019-07-02.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml suspensijos yra	1 ml
Deksametazonas	1 mg
Neomicino sulfatas	3500 TV
Polimiksino B sulfatas	6000 TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
99686	85793	1085793	buteliukas	5 ml N1		Receptinis	LT/L/18/0672/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2018-06-18	Registruotas